14 February 2022 - Ensuring high quality, affordable generic drugs are available to the American public. ...
3 February 2022 - The prices of drugs used to treat COVID-19 for those at risk of serious illness are ...
28 January 2022 - Measuring and valuing health-related quality of life in children can be challenging but is an important component ...
25 January 2022 - Registration now open for 1 February “Early Insights” webinar. Public comment period now open until 22 ...
13 January 2022 - The FDA’s Center for Drug Evaluation and Research has issued its report, Advancing Health Through Innovation: New ...
14 January 2022 - The Public Summary Documents (first time rejections and deferrals) from the September 2021 PBAC meeting are now ...
6 January 2022 - Tirzepatide has a novel dual GIP and GLP-1 receptor agonist mechanism of action and is seen as ...
24 December 2021 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the September 2021 PBAC ...
24 December 2021 - The PBS Expenditure and Prescriptions Report 1 July 2020 to 30 June 2021 is now available. ...
24 December 2021 - The report on the collection of under co-payment data 2020-21 is now available. ...
1 December 2021 - In an open-access publication in the Journal of European CME, two authors from IQWiG argue that ...
25 November 2021 - A new parliamentary report ‘The New Frontier: Delivering better health for all Australians’ is recommending significant ...
25 November 2021 - The Medical Technology Association of Australia wishes to thank Trent Zimmerman MP and Dr Mike Freelander MP ...
24 November 2021 - The outcome statement for the semaglutide stakeholder meeting held on 26 August 2021 is now available. ...
16 November 2021 - Concerns about long-term safety influenced majority of independent appraisal committee to vote that evidence is not currently ...